These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

48 related items for PubMed ID: 21748778

  • 21. The human area postrema and other nuclei related to the emetic reflex express cAMP phosphodiesterases 4B and 4D.
    Mori F, Pérez-Torres S, De Caro R, Porzionato A, Macchi V, Beleta J, Gavaldà A, Palacios JM, Mengod G.
    J Chem Neuroanat; 2010 Sep; 40(1):36-42. PubMed ID: 20347962
    [Abstract] [Full Text] [Related]

  • 22. Specific CD3 epsilon association of a phosphodiesterase 4B isoform determines its selective tyrosine phosphorylation after CD3 ligation.
    Baroja ML, Cieslinski LB, Torphy TJ, Wange RL, Madrenas J.
    J Immunol; 1999 Feb 15; 162(4):2016-23. PubMed ID: 9973473
    [Abstract] [Full Text] [Related]

  • 23. Selective SUMO modification of cAMP-specific phosphodiesterase-4D5 (PDE4D5) regulates the functional consequences of phosphorylation by PKA and ERK.
    Li X, Vadrevu S, Dunlop A, Day J, Advant N, Troeger J, Klussmann E, Jaffrey E, Hay RT, Adams DR, Houslay MD, Baillie GS.
    Biochem J; 2010 Apr 28; 428(1):55-65. PubMed ID: 20196770
    [Abstract] [Full Text] [Related]

  • 24. Expression of phosphodiesterase 4 is altered in the brains of subjects with autism.
    Braun NN, Reutiman TJ, Lee S, Folsom TD, Fatemi SH.
    Neuroreport; 2007 Nov 19; 18(17):1841-4. PubMed ID: 18090323
    [Abstract] [Full Text] [Related]

  • 25. Differential expression of the metallothionein gene in liver and brain of mice and rats.
    Choudhuri S, McKim JM, Klaassen CD.
    Toxicol Appl Pharmacol; 1993 Mar 19; 119(1):1-10. PubMed ID: 8470112
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Levels of phosphodiesterase 4A and 4B are altered by chronic treatment with psychotropic medications in rat frontal cortex.
    Fatemi SH, Folsom TD, Reutiman TJ, Braun NN, Lavergne LG.
    Synapse; 2010 Jul 19; 64(7):550-5. PubMed ID: 20222156
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. In cardiac myocytes, cAMP elevation triggers the down-regulation of transcripts and promoter activity for cyclic AMP phosphodiesterase-4A10 (PDE4A10).
    McCahill A, Campbell L, McSorley T, Sood A, Lynch MJ, Li X, Yan C, Baillie GS, Houslay MD.
    Cell Signal; 2008 Nov 19; 20(11):2071-83. PubMed ID: 18721873
    [Abstract] [Full Text] [Related]

  • 31. Identification and molecular characterization of a novel PDE4D11 cAMP-specific phosphodiesterase isoform.
    Lynex CN, Li Z, Chen ML, Toh KY, Low RW, Goh DL, Tay SK.
    Cell Signal; 2008 Dec 19; 20(12):2247-55. PubMed ID: 18804162
    [Abstract] [Full Text] [Related]

  • 32. Neuronal expression of cAMP-specific phosphodiesterase 7B mRNA in the rat brain.
    Reyes-Irisarri E, Pérez-Torres S, Mengod G.
    Neuroscience; 2005 Dec 19; 132(4):1173-85. PubMed ID: 15857719
    [Abstract] [Full Text] [Related]

  • 33. The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy.
    Cheng JB, Watson JW, Pazoles CJ, Eskra JD, Griffiths RJ, Cohan VL, Turner CR, Showell HJ, Pettipher ER.
    J Pharmacol Exp Ther; 1997 Feb 19; 280(2):621-6. PubMed ID: 9023272
    [Abstract] [Full Text] [Related]

  • 34. Expression and regulation of mRNA for distinct isoforms of cAMP-specific PDE-4 in mitogen-stimulated and leukemic human lymphocytes.
    Jiang X, Paskind M, Weltzien R, Epstein PM.
    Cell Biochem Biophys; 1998 Feb 19; 28(2-3):135-60. PubMed ID: 9515164
    [Abstract] [Full Text] [Related]

  • 35. Regulation of the phosphodiesterase PDE4B3-isotype during long-term potentiation in the area dentata in vivo.
    Ahmed T, Frey S, Frey JU.
    Neuroscience; 2004 Feb 19; 124(4):857-67. PubMed ID: 15026126
    [Abstract] [Full Text] [Related]

  • 36. Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B.
    Manning CD, McLaughlin MM, Livi GP, Cieslinski LB, Torphy TJ, Barnette MS.
    J Pharmacol Exp Ther; 1996 Feb 19; 276(2):810-8. PubMed ID: 8632354
    [Abstract] [Full Text] [Related]

  • 37. Differential type 4 cAMP-specific phosphodiesterase (PDE4) expression and functional sensitivity to PDE4 inhibitors among rats, monkeys and humans.
    Bian H, Zhang J, Wu P, Varty LA, Jia Y, Mayhood T, Hey JA, Wang P.
    Biochem Pharmacol; 2004 Dec 01; 68(11):2229-36. PubMed ID: 15498513
    [Abstract] [Full Text] [Related]

  • 38. Chronic nicotine doses down-regulate PDE4 isoforms that are targets of antidepressants in adolescent female rats.
    Polesskaya OO, Smith RF, Fryxell KJ.
    Biol Psychiatry; 2007 Jan 01; 61(1):56-64. PubMed ID: 16814262
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of rolipram, a selective inhibitor of type 4 phosphodiesterase, on lipopolysaccharide-induced uveitis in rats.
    Chi ZL, Hayasaka S, Zhang XY, Hayasaka Y, Cui HS.
    Invest Ophthalmol Vis Sci; 2004 Aug 01; 45(8):2497-502. PubMed ID: 15277469
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.